Ticker > Company >

Kerala Ayurveda share price

Kerala Ayurveda Ltd.

BSE: 530163 SECTOR: Pharmaceuticals & Drugs  38.56 K   44   1

503.90
+15.20 (3.11%)
BSE: 12 Sep 04:01 PM

Price Summary

Today's High

₹ 503.9

Today's Low

₹ 461.7

52 Week High

₹ 625

52 Week Low

₹ 250

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

606.32 Cr.

Enterprise Value

651.64 Cr.

No. of Shares

1.2 Cr.

P/E

0

P/B

25.19

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  20

CASH

16.48 Cr.

DEBT

61.81 Cr.

Promoter Holding

37.83 %

EPS (TTM)

₹  -8.66

Sales Growth

15.55%

ROE

-1.07 %

ROCE

5.04%

Profit Growth

-109.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.55%
3 Year19.18%
5 Year9.49%

Profit Growth

1 Year-109.41%
3 Year24.68%
5 Year-176.13%

ROE%

1 Year-1.07%
3 Year13.2%
5 Year-1.29%

ROCE %

1 Year5.04%
3 Year8.38%
5 Year5.65%

Debt/Equity

1.5747

Price to Cash Flow

-143.71

Interest Cover Ratio

1.1062

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 37.83 20.69
Mar 2025 58.58 13.36
Dec 2024 58.58 13.36
Sep 2024 58.58 13.36
Jun 2024 58.58 13.36
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 24.8310818046588% for the Past 3 years.
  • The company has shown a good revenue growth of 19.1835457888445% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -13.4218 days.
  • Company has a healthy liquidity position with current ratio of 2.016.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 19.2916094762421.

 Limitations

  • Promoter pledging has increased from 13.3599444415675% to 20.69% in 1 quarter.
  • Company has negative cash flow from operations of -4.219.
  • Promoter stake has been decreased from 58.58% to 37.83%.
  • Promoter pledging is high as 20.69%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 15.4 18.6 19.35 19.35 17.57
Total Expenditure 16.8 19.15 18.99 30.34 22.99
Operating Profit -1.41 -0.55 0.37 -11 -5.43
Other Income 0.27 0.39 0.13 4.37 10
Interest 0.4 0.33 0.38 2.81 0.77
Depreciation 0.19 0.22 0.28 1.46 1.23
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.73 -0.71 -0.16 -10.88 2.58
Tax -0.43 -0.17 -0.08 0.98 0.51
Profit After Tax -1.29 -0.54 -0.08 -11.86 2.07
Adjusted EPS (Rs) -1.08 -0.45 -0.07 -9.86 1.72

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 53.68 43.2 55.8 63.3 73.14
Total Expenditure 50.58 43 48.07 58.54 68.13
Operating Profit 3.11 0.21 7.73 4.76 5.01
Other Income 0.16 0.17 0.3 0.23 0.21
Interest 1.37 6.14 6.03 4.81 4.02
Depreciation 0.68 0.82 0.77 0.64 0.77
Exceptional Items 0 0 0 2.83 0
Profit Before Tax 1.22 -6.58 1.23 2.37 0.43
Tax 0.34 -1.63 0.35 -0.52 0.7
Net Profit 0.88 -4.95 0.89 3.26 -0.31
Adjusted EPS (Rs.) 0.83 -4.69 0.84 2.74 -0.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.56 10.56 10.56 10.56 12.03
Total Reserves 4.11 -0.51 0.72 3.98 30.34
Borrowings 47.16 47.85 28.76 48.92 51.64
Other N/C liabilities 9.49 7.83 4.16 3.75 5.07
Current liabilities 22.28 29.79 47.13 30.61 24.78
Total Liabilities 93.6 95.51 91.33 97.81 123.86
Assets
Net Block 17.09 16.8 27.96 30.32 30.25
Capital WIP 11.55 11.98 2.34 0 0
Intangible WIP 0 0 0 0 0
Investments 11.47 11.37 11.37 11.37 11.37
Loans & Advances 23.03 24.5 22.07 27.12 28.99
Other N/C Assets 3.08 3.07 4.19 3.04 3.3
Current Assets 27.38 27.8 23.39 25.97 49.96
Total Assets 93.6 95.51 91.33 97.81 123.86
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2.44 -0.53 7.12 6.81 4.25
Adjustment 0.82 0.97 0.81 0.95 0.57
Changes in Assets & Liabilities 1.45 -1.35 0.82 1.35 -9.04
Tax Paid 0 0 0 0 0
Operating Cash Flow 4.71 -0.91 8.75 9.12 -4.22
Investing Cash Flow -3.93 -2.1 0.83 -5.32 -2.18
Financing Cash Flow 0.29 2.18 -10.52 -2.27 21.15
Net Cash Flow 1.06 -0.83 -0.94 1.52 14.75

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 58.58 58.58 58.58 58.58 37.83
katra holdings ltd 53.97 53.97 53.97 53.97 33.22
katra phytochem (india) p... 4.61 4.61 4.61 4.61 4.61
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 41.42 41.42 41.42 41.42 62.17
aamara capital private li... - - - - 1.50
anilkumar k - - - - 1.47
bharat taparia - - - - 1.58
dheeraj kumar lohia 2.03 2.03 2.03 1.93 1.68
nimish chandulal shah - - - - 1.99
porinju veliyath 5.18 5.18 5.18 5.18 4.51
pradeep ghisulal rathod - - - - 1.26
riddisiddhi bullions limi... - - - - 1.42
sanjiv dhireshbhai shah... 2.89 2.89 2.89 2.55 2.44
santosh industries limite... - - - - 2.00
sashikanth balachandar 1.26 1.26 1.26 1.26 1.07
setu securities pvt ltd - - - - 1.42
trishakti power holdings ... - - - - 1.14
anil kumar k 1.59 1.57 1.55 1.53 -
llp 0.56 - 0.55 0.55 -

Annual Reports

Title Link
Title Link
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Kerala Ayurveda informs about updates 11 Sep, 12:50 PM Kerala Ayurveda informs about press release 19 Jul, 11:29 AM Kerala Ayurveda - Quaterly Results 18 Jul, 9:47 PM Kerala Ayurveda - Quaterly Results 18 Jul, 9:47 PM Kerala Ayurveda informs about compliance certificate 8 Jul, 2:32 PM Kerala Ayurveda informs about newspaper publication 11 Jun, 10:01 AM Kerala Ayurveda - Quaterly Results 27 May, 1:55 AM Kerala Ayurveda - Quaterly Results 27 May, 1:55 AM Kerala Ayurveda - Quaterly Results 27 May, 1:55 AM Kerala Ayurveda informs about certificate 5 Apr, 9:40 AM Kerala Ayurveda informs about compliance certificate 6 Jan, 3:26 PM Kerala Ayurveda informs about update in registered office address 30 Nov, 10:40 AM Kerala Ayurveda informs about closure of trading window 11 Oct, 9:57 AM Kerala Ayurveda informs about issuance of duplicate share certificates 21 Aug, 11:24 AM Kerala Ayurveda - Quaterly Results 14 Aug, 6:35 PM Kerala Ayurveda acquires 51% stake in Om Vedic Heritage Centre 8 Aug, 11:21 AM Kerala Ayurveda - Quaterly Results 14 Feb, 3:29 PM Kerala Ayurveda - Quaterly Results 14 Feb, 3:29 PM Kerala Ayurveda informs about certificate 6 Jan, 9:52 AM Kerala Ayurveda - Quaterly Results 14 Nov, 12:00 PM Kerala Ayurveda - Quaterly Results 14 Nov, 12:00 PM Kerala Ayurveda informs about disclosure 12 Oct, 12:34 PM Kerala Ayurveda informs about certificate 6 Oct, 10:45 AM Kerala Ayurveda informs about book closure 8 Sep, 3:30 PM Kerala Ayurveda informs about AGM notice 6 Sep, 9:54 AM Kerala Ayurveda - Quaterly Results 10 Aug, 4:14 PM Kerala Ayurveda - Quaterly Results 10 Aug, 4:14 PM Kerala Ayurveda gets nod to enter into BTA for purchase of Nutraceutical product range 12 Jul, 4:17 PM Kerala Ayurveda informs about compliance certificate 4 Jul, 11:55 AM Kerala Ayurveda informs about press release 15 Feb, 2:33 PM Kerala Ayurveda - Quaterly Results 14 Feb, 1:54 PM Kerala Ayurveda receives patent from USPTO 14 Dec, 4:22 PM Kerala Ayurveda informs about closure of trading window 1 Oct, 4:03 PM Kerala Ayurveda informs about trading window closure 29 Jun, 5:11 PM Kerala Ayurveda informs about on-applicability of large corporate entity 13 Apr, 12:55 PM Kerala Ayurveda informs about closure of trading window 30 Dec, 12:13 PM Kerala Ayurveda informs about disclosure 18 Dec, 10:51 AM Kerala Ayurveda informs about updates 20 Nov, 12:18 PM Kerala Ayurveda Informs about proceedings of AGM 1 Oct, 12:42 PM Kerala Ayurveda informs about board meeting 7 Aug, 4:46 PM Kerala Ayurveda informs about RTA certificate 5 Jul, 2:46 PM Kerala Ayurveda informs about declaration 3 Jul, 2:09 PM Kerala Ayurveda informs about compliance report 30 Jun, 5:02 PM Kerala Ayurveda informs about closure of trading window 29 Jun, 10:46 AM Kerala Ayurveda partners with eBay 4 Mar, 12:37 PM Kerala Ayurveda informs about press release 4 Mar, 10:40 AM Kerala Ayurveda informs about notice of board meeting 4 Nov, 1:34 PM Kerala Ayurveda launches Tele-Consultation ‘DigiApp’ 4 Nov, 10:17 AM Kerala Ayurveda informs about compliance certificate 7 Oct, 10:35 AM Kerala Ayurveda informs about related party transactions 18 Jul, 3:21 PM

Kerala Ayurveda Stock Price Analysis and Quick Research Report. Is Kerala Ayurveda an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Kerala Ayurveda. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Kerala Ayurveda has a PE ratio of -58.198491620757 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Kerala Ayurveda has ROA of -0.2447% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Kerala Ayurveda has a Current ratio of 2.016.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Kerala Ayurveda has a ROE of -1.0653%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Kerala Ayurveda has a Debt to Equity ratio of 1.5747 which means that the company has low proportion of debt in its capital.

  • Sales growth: Kerala Ayurveda has reported revenue growth of 15.5493% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Kerala Ayurveda for the current financial year is 6.84470585661706%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Kerala Ayurveda is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Kerala Ayurveda is Rs -8.6583. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Kerala Ayurveda in Ticker for free. Also, one can get the intrinsic value of Kerala Ayurveda by using Valuation Calculators, which are available with a Finology ONE subscription. 

Kerala Ayurveda FAQs

Q1. What is Kerala Ayurveda share price today?
Ans: The current share price of Kerala Ayurveda is Rs 503.9.

Q2. What is the market capitalisation of Kerala Ayurveda?
Ans: Kerala Ayurveda has a market capitalisation of Rs 606.31520589 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Kerala Ayurveda?
Ans: The PE ratio of Kerala Ayurveda is -58.198491620757 and the P/B ratio of Kerala Ayurveda is 25.1937403129844, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Kerala Ayurveda share?
Ans: The 52-week high share price of Kerala Ayurveda is Rs 625, and the 52-week low share price of Kerala Ayurveda is Rs 250.

Q5. Does Kerala Ayurveda pay dividends?
Ans: Currently, Kerala Ayurveda does not pay dividends. Dividend yield of Kerala Ayurveda is around 0%.

Q6. What are the face value and book value of Kerala Ayurveda shares?
Ans: The face value of Kerala Ayurveda shares is Rs 10, while the book value per share of Kerala Ayurveda is around Rs 20.001. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Kerala Ayurveda?
Ans: Kerala Ayurveda has a total debt of Rs 61.806 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Kerala Ayurveda?
Ans: The ROE of Kerala Ayurveda is -1.0653% and ROCE of Kerala Ayurveda is 5.0427%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Kerala Ayurveda a good buy for the long term?
Ans: The Kerala Ayurveda long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Kerala Ayurveda undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Kerala Ayurveda appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Kerala Ayurveda’s financials?
Ans: You can review Kerala Ayurveda’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Kerala Ayurveda
X